top of page
Summary of Cancer52 / PHE Event: Development in Data for Rare and Less Common Cancers
Cancer52 and PHE/NCRAS are delighted to be able to share a film and a report of the very successful Developments in Data for Rare and...
‘Getting a better deal for people with rare and less common cancers: what we can learn from patients
On Wednesday 10th July we launched a new report, ‘Getting a better deal for people with rare and less common cancers: what we can learn...
Getting a better deal for people with rare and less common cancers: the next ten years
We're excited to announce the publication of our new briefing document 'Getting a better deal for people with rare and less common...
“Clinical Nurse Specialists working with people with rare and less common cancers”
Available from 6th December 2016 to mark the Cancer52 session at Britain Against Cancer – a new report from Cancer52 on the role of the...
“Living with a rare or less common cancer, patient experiences of treatment and care”
Our new patient experience report - what does the evidence from the National Cancer Patient Experience Survey show us about experience...
“Speaking up for patients - Patient organisation involvement in Health Technology Assessment (HTA) w
A new report on patient group involvement in the new Patient and Clinical Engagement (PACE) process at the Scottish Medicines Consortium...
“Rare and Less Common Cancers: Incidence and Mortality in England, 2010 to 2013”
We are delighted to announce that our new report “Rare and Less Common Cancers: Incidence and Mortality in England, 2010 to 2013” is...
New report from Cancer52: percentage of cancer deaths outside the big four rises to 54%
A new report published today (Tuesday 10th June 2014) by Cancer52 shows that the percentage of cancer deaths from those cancers outside...
NCRI and Cancer52 publish report on research spend
The National Cancer Research Institute (NCRI) and Cancer52 have published a report "Research into less common cancers". It shows for the...
Cancer52 Third Annual Briefing 2013
Cancer52's Third Annual Briefing was held in October 2013 at the House of Lords. To read a summary debrief of the event please click here.
bottom of page